Search

everythinglearnresearchcommunity

for

Search:↓

Gender affects the symptoms and severity of systemic lupus erythematosus.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

COVID-19 vaccination may trigger lupus in some people.

Laser treatment increases hair density and thickness safely in women with hair loss.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Finasteride for hair loss has minimal impact on sexual function.

Hair loss in lupus patients indicates higher disease activity.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Rats had lasting erectile problems after stopping a certain medication.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Early scar classification in lupus can improve treatment and patient outcomes.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

A woman with lupus and severe nerve damage improved with specific treatments.